Nurse Practitioner, Family · Detroit, MI
NPI
1306844998
Since 2005
Specialty
Nurse Practitioner, Family
Code 363LF0000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
3901 Chrysler Dr, Ste 4a
Detroit, MI, 48201
Phone (313) 745-4525
Groups this clinician bills Medicare through
Medicare paid, 2024
$1,927
73 services
Medicare patients, 2024
19
Average age 60
Drug cost, 2024
$2.5M
822 prescriptions
Company payments, 2024
$19.64
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Belverly J Jones was code 99213 (office e&m - established), 24 times for 16 patients. In total Belverly J Jones billed 73 services in 11 codes, and Medicare paid $1,927.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 24 | 16 | $41.06 | $985 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 13 | 11 | $9.01 | $117 |
By year: 2022 $9,717 for 555 services; 2023 $2,506 for 68 services; 2024 $1,927 for 73 services.
Medicare prescription drug claims, 2024
In 2024, the drug Belverly J Jones prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 237 prescriptions and refills. In total Belverly J Jones wrote 822 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 237 | 247 | 28 | $957K |
| Cabenuva Cabotegravir/Rilpivirine | 105 | 202 | 20 | $704K |
| Juluca Dolutegravir/Rilpivirine | 58 | 58 | Under 11 | $201K |
| Tivicay Dolutegravir Sodium | 54 | 54 | Under 11 | $119K |
| Dovato Dolutegravir Sodium/Lamivudine | 51 | 51 | Under 11 | $145K |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 44 | 44 | Under 11 | $154K |
| Descovy Emtricitabine/Tenofov Alafenam | 42 | 42 | Under 11 | $92K |
| Atorvastatin Calcium Generic | 22 | 22 | Under 11 | $67.93 |
| Tamsulosin Hcl Generic | 17 | 17 | Under 11 | $29.06 |
| Prezcobix Darunavir/Cobicistat | 17 | 17 | Under 11 | $39K |
| Hydrochlorothiazide Generic | 16 | 16 | Under 11 | $9.27 |
| Maraviroc Generic | 13 | 13 | Under 11 | $17K |
| Lisinopril Generic | 12 | 12 | Under 11 | $10.24 |
Brand drugs: 638 claims; generic drugs: 184 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Belverly J Jones $19.64 ($19.64 in general payments such as food, travel and fees) from 1 company. The largest payer was Gilead Sciences, Inc. with $19.64.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 1 | $19.64 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.